Sunshine Biopharma (SBFM) Notes Payables (2012 - 2021)
Sunshine Biopharma's (SBFM) quarterly Notes Payables came in at $330000.0 in Q3 2021, down 37.76% YoY from $530209.0 in Q3 2020, and little changed on a QoQ basis from $330000.0 in Q2 2021.
Sunshine Biopharma (SBFM) Notes Payables (2012 - 2021) Analysis & Trends
Sunshine Biopharma (SBFM) has 9 years of Notes Payables data on file, last reported at $330000.0 in Q3 2021.
- Quarterly Notes Payables fell 37.76% year-over-year to $330000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $330000.0 (down 37.76% YoY) and the FY2020 annual result came in at $143661.0, up 11.14% from the prior year.
- Notes Payables steadied at $330000.0 in Q3 2021, from $330000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $745397.0 in Q1 2019 to a low of $3915.0 in Q1 2018.
- A 5-year average of $271364.8 and a median of $200177.0 in 2017 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2018 — Notes Payables plunged 97.87% — and 2019, when it jumped 18939.51%.
- Tracing SBFM's Notes Payables over 5 years: stood at $516867.0 in 2017, then declined by 18.81% to $419663.0 in 2018, then tumbled by 69.2% to $129261.0 in 2019, then rose by 11.14% to $143661.0 in 2020, then soared by 129.71% to $330000.0 in 2021.
- The last three Notes Payables figures came in at $330000.0 (Q3 2021), $330000.0 (Q2 2021), and $143661.0 (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 330,000.00 |
| Jun 30, 2021 | 330,000.00 |
| Mar 31, 2021 | 143,661.00 |
| Dec 31, 2020 | 143,661.00 |
| Sep 30, 2020 | 530,209.00 |
| Jun 30, 2020 | 128,269.00 |
| Mar 31, 2020 | 513,407.00 |
| Dec 31, 2019 | 129,261.00 |
| Sep 30, 2019 | 88,751.00 |
| Jun 30, 2019 | 89,808.00 |
| Mar 31, 2019 | 745,397.00 |
| Dec 31, 2018 | 419,663.00 |
| Sep 30, 2018 | 225,195.00 |
| Jun 30, 2018 | 242,672.00 |
| Mar 31, 2018 | 3,915.00 |
| Dec 31, 2017 | 516,867.00 |
| Sep 30, 2017 | 200,177.00 |
| Jun 30, 2017 | 191,129.00 |
| Mar 31, 2017 | 183,889.00 |
| Dec 31, 2016 | 69,939.00 |